All the news in China on Sinopharm and Sinovac vaccines

All the news in China on Sinopharm and Sinovac vaccines

All the latest news in China on Sinopharm and Sinovac vaccines

Nearly one million people in China have taken an emergency Covid-19 vaccine that is still being tested, the company that developed the vaccine said.

Chinese authorities released the vaccine, developed by the China National Pharmaceutical Group (Sinopharm), to select groups of people in July, including Chinese government officials, students, and workers traveling overseas, before the vaccines had proven. to work – writes The Guardian .

Sinopharm's claims, released in an interview with President Liu Jingzhen published on WeChat , did not specify which of his vaccines had been administered, but stated that individuals had traveled to more than 150 countries around the world and that "there is no there was only one case of infection after inoculation ”. "Only individual patients have had some mild symptoms," he said.

Sinopharm's two vaccines are among five Chinese candidates undergoing international clinical trials because the internal prevalence of the disease is so low.

At least three – all of Sinopharm's and Sinovac's inactivated vaccines – have been approved for emergency use outside clinical trials, and some local governments have allowed residents to take the Sinovac vaccine.

In September, the UAE was the first country outside of China to approve the emergency use of the Sinopharm vaccine.

The overseas trials have sparked some controversy, partly due to a lack of communication from the Chinese authorities. In August, 48 Chinese construction workers were barred from entering Papua New Guinea for fear of being given an unnamed experimental vaccine.

More broadly, however, the decision by countries like China and Russia to proceed with vaccination programs before completing the full tests, including the large-scale Phase 3 trials, has been viewed with concern elsewhere.

Experts warned that taking shortcuts to internationally accepted approaches to testing and regulation could fuel wider public distrust of coronavirus vaccines and potentially reduce the uptake required for effective protection of the populations.

China has pledged to supply its vaccines to more countries, delivering potentially conflicting promises to prioritize places like the Philippines and nations in Africa.

Speaking at the Apec conference on Thursday, Chinese President Xi Jinping promised closer international coordination on vaccine development and distribution policies.

(Extract from the foreign press review by Epr Comunicazione)

This is a machine translation from Italian language of a post published on Start Magazine at the URL on Sun, 22 Nov 2020 07:19:26 +0000.